According to the report published by Zion Market Research, global demand for the Antibody Production market was valued at approximately USD 10.86 Billion in 2019 and is expected to generate revenue of around USD 24.00 Billion by end of 2026, growing at a CAGR of around 12.01% between 2020 and 2026.
According to the report published by Zion Market Research, global demand for the Antibody Production market was valued at approximately USD 10.86 Billion in 2019 and is expected to generate revenue of around USD 24.00 Billion by end of 2026, growing at a CAGR of around 12.01% between 2020 and 2026.
Global Antibody Production Market: Overview
The immune system produces antibodies secreted in the blood, which are protein molecules produced in response to the antigens, foreign particles such as viruses, fungi, and bacteria. The antibodies function by neutralizing or inhibiting the antigen activity. The production of an antibody is dependent on the humoral response of the immune system to the introduction of foreign particles into the body. Polyclonal antibodies and monoclonal antibodies are the basic types of antibodies produced by the immune system. Polyclonal antibodies are produced from many dissimilar immune cells whereas monoclonal antibodies are produced by similar immune cells which are duplicates of a distinctive progenitor cell. The antibody production market consists of products essential for various steps of processing of antibodies, such as downstream processing, filtration, and upstream processing.
Global Antibody Production Market: Growth Factors
The major factors contributing to the growth of the antibody production market are the increasing need for protein curatives and the rising widespread presence of infectious disease. The other factors propelling the growth of the market are the patent cessation of successful monoclonal antibodies, raised R&D disbursement of biotechnology and pharmaceutical companies, rising acceptance of targeted immunotherapy, and therapeutic antibodies by governing authorities.
Global Antibody Production Market: Segmentation
The antibody production market may be classified based on end-users and process. The end-users segment of the global market can be further divided into research institutes, diagnostic laboratories, and biotechnology and pharmaceutical companies. The biotechnology and pharmaceutical companies segment is anticipated to grow the most owing to the huge digit of drug development processes to meet the decreased industry timelines, attracting the companies to invest in the developmental and research activities. The process segment of the market may be divided into filtration, upstream processing, and downstream processing. The filtration segment of the market can be further categorized as filtration consumables and accessories and filtration systems. The upstream segment of the global antibody production market can be diversified into consumables and bioreactors. The consumables segment is sub-segmented as buffers & reagents and the media and bioreactors segment is sub-segmented as single-use bioreactors and large-scale bioreactors. The downstream segment can be categorized into chromatography resins and chromatography systems. The need for advanced and sensitive tools is expected to boost the growth of the downstream processing segment.
The antibody production market can also be segmented on the basis of application and type. The application segment of the market is further classified into cardiology, rheumatology, hematology/oncology, gastroenterology, transplantation, and infection. The type segment of the antibody production market can be categorized into polyclonal antibodies and monoclonal antibodies. The monoclonal antibody segment is further sub-segmented into humanized, murine, and chimeric.
Region-wise, the global market is segregated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Global Antibody Production Market: Regional Analysis
North America is anticipated to be the rapidly growing region in the antibody production market due to government expenditure, increasing cancer incidence, and the requirement for quality cancer therapy. The Asia-Pacific region is also expected to boost in the market owing to the rising private sector and government expenditure, increasing infrastructural advancements, and government support.
Global Antibody Production Market: Competitive Players
The major players in the antibody production market are Sigma-Aldrich Corporation, GE Healthcare, Thermo Fisher Scientific, Inc., INTEGRA Biosciences AG, Cellab GmbH, and Eppendorf AG. The other prominent players in the market include Sartorius AG, Pall Corporation, Merck KGaA, and FiberCell Systems Inc.
Antibody Production Market: Regional Segment Analysis
List of Figures
FIG. 1 Research Methodology
FIG. 2 Research Methodology – Basic Overview
FIG. 3 Research Methodology – Detailed View
FIG. 4 Global Antibody Production Market Revenue, 2016 - 2026 (USD Million)
FIG. 5 Porter’s Five Forces Analysis for Global Antibody Production Market
FIG. 6 Global Antibody Production Market Attractiveness, By End User
FIG. 7 Global Antibody Production Market Attractiveness, By Process
FIG. 8 Global Antibody Production Market Attractiveness, By Filtration Segment
FIG. 9 Global Antibody Production Market Attractiveness, By Upstream Segment
FIG. 10 Global Antibody Production Market Attractiveness, By Consumables
FIG. 11 Global Antibody Production Market Attractiveness, By Bioreactors
FIG. 12 Global Antibody Production Market Attractiveness, By End-User
FIG. 13 Company Share Analysis, 2019
FIG. 14 Global Antibody Production Market Revenue Share, by End User, 2019 & 2026
FIG. 15 Global Antibody Production Market for Research Institutes, Revenue (USD Million) 2016 - 2026
FIG. 16 Global Antibody Production Market for Diagnostic Laboratories, Revenue (USD Million) 2016 - 2026
FIG. 17 Global Antibody Production Market for Biotechnology, Revenue (USD Million) 2016 - 2026
FIG. 18 Global Antibody Production Market for Pharmaceutical Companies, Revenue (USD Million) 2016 - 2026
FIG. 19 Global Antibody Production Market Revenue Share, by Process, 2019 & 2026
FIG. 20 Global Antibody Production Market for Filtration, Revenue (USD Million) 2016 - 2026
FIG. 21 Global Antibody Production Market for Upstream Processing, Revenue (USD Million) 2016 - 2026
FIG. 22 Global Antibody Production Market for Downstream Processing, Revenue (USD Million) 2016 - 2026
FIG. 23 Global Antibody Production Market Revenue Share, by Filtration Segment, 2019 & 2026
FIG. 24 Global Antibody Production Market for Filtration Consumables and Accessories, Revenue (USD Million) 2016 - 2026
FIG. 25 Global Antibody Production Market for Filtration Systems, Revenue (USD Million) 2016 - 2026
FIG. 26 Global Antibody Production Market Revenue Share, by Upstream Segment, 2019 & 2026
FIG. 27 Global Antibody Production Market for Consumables, Revenue (USD Million) 2016 - 2026
FIG. 28 Global Antibody Production Market for Bioreactors, Revenue (USD Million) 2016 - 2026
FIG. 29 Global Antibody Production Market Revenue Share, by Consumables, 2019 & 2026
FIG. 30 Global Antibody Production Market for Buffers & Reagents, Revenue (USD Million) 2016 - 2026
FIG. 31 Global Antibody Production Market for Media, Revenue (USD Million) 2016 - 2026
FIG. 32 Global Antibody Production Market Revenue Share, by Bioreactors, 2019 & 2026
FIG. 33 Global Antibody Production Market for Single-Use Bioreactors, Revenue (USD Million) 2016 - 2026
FIG. 34 Global Antibody Production Market for Large-Scale Bioreactors, Revenue (USD Million) 2016 - 2026
FIG. 35 Global Antibody Production Market Revenue Share, by Region, 2019 & 2026
FIG. 36 North America Antibody Production Market Revenue, 2016 - 2026 (USD Million)
FIG. 37 Europe Antibody Production Market Revenue, 2016 - 2026 (USD Million)
FIG. 38 Asia Pacific Antibody Production Market Revenue, 2016 - 2026 (USD Million)
FIG. 39 Latin America Antibody Production Market Revenue, 2016 - 2026 (USD Million)
FIG. 40 The Middle-East and Africa Antibody Production Market Revenue, 2016 - 2026 (USD Million)
FIG. 41 Sigma-Aldrich Corporatio Business Segment Revenue Share, 2018 (%)
FIG. 42 Sigma-Aldrich Corporatio Geographical Segment Revenue Share, 2018 (%)
List of Tables
TABLE 1 Global Antibody Production Market: Snapshot
TABLE 2 Drivers of the Antibody Production Market: Impact Analysis
TABLE 3 Restraints for the Antibody Production Market: Impact Analysis
TABLE 4 Global Antibody Production Market Revenue, by Region, 2016 – 2026 (USD Million)
TABLE 5 North America Antibody Production Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 6 North America Antibody Production Market Revenue, by End User, 2016 – 2026 (USD Million)
TABLE 7 North America Antibody Production Market Revenue, by Process, 2016 – 2026 (USD Million)
TABLE 8 North America Antibody Production Market Revenue, by Filtration Segment, 2016 – 2026 (USD Million)
TABLE 9 North America Antibody Production Market Revenue, by Upstream Segment, 2016 – 2026 (USD Million)
TABLE 10 North America Antibody Production Market Revenue, by Consumables, 2016 – 2026 (USD Million)
TABLE 11 North America Antibody Production Market Revenue, by Bioreactors, 2016 – 2026 (USD Million)
TABLE 12 Europe Antibody Production Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 13 Europe Antibody Production Market Revenue, by End User, 2016 – 2026 (USD Million)
TABLE 14 Europe Antibody Production Market Revenue, by Process, 2016 – 2026 (USD Million)
TABLE 15 Europe Antibody Production Market Revenue, by Filtration Segment, 2016 – 2026 (USD Million)
TABLE 16 Europe Antibody Production Market Revenue, by Upstream Segment, 2016 – 2026 (USD Million)
TABLE 17 Europe Antibody Production Market Revenue, by Consumables, 2016 – 2026 (USD Million)
TABLE 18 Europe Antibody Production Market Revenue, by Bioreactors, 2016 – 2026 (USD Million)
TABLE 19 Asia Pacific Antibody Production Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 20 Asia Pacific Antibody Production Market Revenue, by End User, 2016 – 2026 (USD Million)
TABLE 21 Asia Pacific Antibody Production Market Revenue, by Process, 2016 – 2026 (USD Million)
TABLE 22 Asia Pacific Antibody Production Market Revenue, by Filtration Segment, 2016 – 2026 (USD Million)
TABLE 23 Asia Pacific Antibody Production Market Revenue, by Upstream Segment, 2016 – 2026 (USD Million)
TABLE 24 Asia Pacific Antibody Production Market Revenue, by Consumables, 2016 – 2026 (USD Million)
TABLE 25 Asia Pacific Antibody Production Market Revenue, by Bioreactors, 2016 – 2026 (USD Million)
TABLE 26 Latin America Antibody Production Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 27 Latin America Antibody Production Market Revenue, by End User, 2016 – 2026 (USD Million)
TABLE 28 Latin America Antibody Production Market Revenue, by Process, 2016 – 2026 (USD Million)
TABLE 29 Latin America Antibody Production Market Revenue, by Filtration Segment, 2016 – 2026 (USD Million)
TABLE 30 Latin America Antibody Production Market Revenue, by Upstream Segment, 2016 – 2026 (USD Million)
TABLE 31 Latin America Antibody Production Market Revenue, by Consumables, 2016 – 2026 (USD Million)
TABLE 32 Latin America Antibody Production Market Revenue, by Bioreactors, 2016 – 2026 (USD Million)
TABLE 33 The Middle-East and Africa Antibody Production Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 34 The Middle-East and Africa Antibody Production Market Revenue, by End User, 2016 – 2026 (USD Million)
TABLE 35 The Middle-East and Africa Antibody Production Market Revenue, by Process, 2016 – 2026 (USD Million)
TABLE 36 The Middle-East and Africa Antibody Production Market Revenue, by Filtration Segment, 2016 – 2026 (USD Million)
TABLE 37 The Middle-East and Africa Antibody Production Market Revenue, by Upstream Segment, 2016 – 2026 (USD Million)
TABLE 38 The Middle-East and Africa Antibody Production Market Revenue, by Consumables, 2016 – 2026 (USD Million)
TABLE 39 The Middle-East and Africa Antibody Production Market Revenue, by Bioreactors, 2016 – 2026 (USD Million)
Request the coronavirus impact analysis across industries and markets
The major factors contributing to the growth of the antibody production market are the increasing need for protein curatives and the rising widespread presence of infectious disease. The other factors propelling the growth of the market are the patent cessation of successful monoclonal antibodies, raised R&D disbursement of biotechnology and pharmaceutical companies, rising acceptance of targeted immunotherapy, and therapeutic antibodies by governing authorities.
According to Zion Market Research, global demand for the Antibody Production market is expected to generate revenue of around USD 24.00 Billion by end of 2026, growing at a CAGR of around 12.01% between 2020 and 2026.
North America is anticipated to be the rapidly growing region in the antibody production market due to government expenditure, increasing cancer incidence, and the requirement for quality cancer therapy.
Some main participants of the Antibody Production market are Sigma-Aldrich Corporation, GE Healthcare, Thermo Fisher Scientific, Inc., INTEGRA Biosciences AG, Cellab GmbH, and Eppendorf AG. The other prominent players in the maharvcerket include Sartorius AG, Pall Corporation, Merck KGaA, and FiberCell Systems Inc. .
Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No 020-46277770
US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed